TickerFactsScreenerDevelopers

Aptevo Therapeutics Inc. (APVO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$41.57M2018: -$51.42M2019: -$42.38M2020: -$29.32M2021: -$21.68M2022: -$21.02M2023: -$11.73M2024: -$23.79M2025: -$25.59M-$25.59M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$25.59M-7.6%
2024-$23.79M-102.8%
2023-$11.73M+44.2%
2022-$21.02M+3.0%
2021-$21.68M+26.1%
2020-$29.32M+30.8%
2019-$42.38M+17.6%
2018-$51.42M-23.7%
2017-$41.57M—